DE MATTEIS, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 341
EU - Europa 278
AS - Asia 143
SA - Sud America 1
Totale 763
Nazione #
US - Stati Uniti d'America 341
CN - Cina 140
IE - Irlanda 72
UA - Ucraina 59
FI - Finlandia 28
IT - Italia 27
GB - Regno Unito 25
DE - Germania 24
SE - Svezia 20
BE - Belgio 12
FR - Francia 10
SG - Singapore 2
BR - Brasile 1
HK - Hong Kong 1
NL - Olanda 1
Totale 763
Città #
Chandler 98
Dublin 72
Jacksonville 68
Ann Arbor 49
Nanjing 41
Nanchang 24
Brussels 12
Medford 12
Pavia 12
Princeton 12
Ashburn 11
Lawrence 11
Hebei 10
Jiaxing 10
Shanghai 10
Beijing 9
Shenyang 9
Milan 8
Tianjin 8
Wilmington 7
Changsha 6
Hangzhou 6
Woodbridge 6
Boardman 5
Norwalk 5
Des Moines 4
Helsinki 4
Los Angeles 3
Verona 3
Auburn Hills 2
Jinan 2
Kunming 2
Saint-Fons 2
Turin 2
Central 1
Huizen 1
Melegnano 1
Ningbo 1
Rockville 1
Seattle 1
São Paulo 1
Totale 552
Nome #
Calamitic and antinematic orientational order produced by the generalized Straley lattice model 94
Universal mean-field phase diagram for biaxial nematics obtained from a minimax principle 82
Biaxial and uniaxial phases produced by partly repulsive mesogenic models involving $D_{2h}$ molecular symmetries 81
Director libration in nematoacoustics 74
Criterion for tricritical points in liquid crystal phases 73
Constrained stability for biaxial nematic phases 61
Bifurcation analysis and computer simulation of biaxial liquid crystals 60
Tricritical points in biaxial liquid crystal phases 58
Landau theory for biaxial nematic liquid crystals with two order parameter tensors 56
Mesogenic lattice models with partly antinematic interactions producing uniaxial nematic phases. 51
Orientationally ordered phases produced by fully antinematic interactions: a simulation study. 48
Erratum to "Orientationally ordered phase produced by fully antinematic interactions:A simulation study" [Physical Review E v=84, 011703 (2011)] 36
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 8
Totale 782
Categoria #
all - tutte 2.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020184 49 67 1 12 2 12 1 13 1 18 7 1
2020/2021116 13 13 4 11 1 14 2 18 4 17 15 4
2021/202262 3 1 1 3 1 3 1 5 4 1 8 31
2022/2023229 17 25 5 24 23 30 0 12 84 1 6 2
2023/202449 3 13 2 2 6 5 0 2 0 2 4 10
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 782